ODTX Odyssey Therapeutics, Inc.: institutional ownership and insider trading
60 funds reported holding $653M of Odyssey Therapeutics, Inc. in their latest 13F filings; in Q2 2026 funds net bought $653M, with 59 new positions and 0 funds selling out; over the last 12 months insiders bought $75.3M and sold $32.0K on the open market.
ODTX revenue and earnings
- Quarter ended Jun 30, 2026: revenue $0, net income −$52.8M, EPS -1.74
- Quarter ended Mar 31, 2026: revenue $0, net income −$38.3M, EPS -6.77
- Quarter ended Jun 30, 2025: revenue $959K, net income −$41.2M, EPS -29.54
- Quarter ended Mar 31, 2025: revenue $1.92M, net income −$38.4M, EPS -39.37
Famous investors holding ODTX
- Ken Griffin (Citadel Advisors): $4.16M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $2.93M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $371K, 0.0% of the portfolio
Largest institutional holders of ODTX
- FMR LLC — $96.9M
- SR ONE CAPITAL MANAGEMENT, LP — $71.0M
- TPG GP A, LLC — $69.0M
- Lightspeed Management Company, L.L.C. — $67.5M
- ORBIMED ADVISORS LLC — $56.2M
- Sanofi (SNY, SNYNF) — $37.3M
- DEERFIELD MANAGEMENT COMPANY, L.P. — $19.6M
- Sands Capital Alternatives, LLC — $16.4M
- HHLR ADVISORS, LTD. — $15.6M
- General Catalyst Group Management, LLC — $15.2M
Recent ODTX insider trades
- May 11, 2026: Coulter James G bought 1,388,889 shares ($25.0M)
- May 11, 2026: Li Nan (LN) bought 1,111,111 shares ($20.0M)
- May 11, 2026: Chu Shelley bought 11,111 shares ($200K)
- May 11, 2026: George Simeon bought 555,555 shares ($10.00M)
5%+ owners
- FMR LLC: 10.2% (Schedule 13G, filed Jun 5, 2026)
- SR One Capital Management, LLC: 8.0% (Schedule 13D, filed May 18, 2026)
- TPG GP A, LLC: 7.8% (Schedule 13D, filed May 18, 2026)
- Jeito II S.L.P.: 7.8% (Schedule 13D, filed May 15, 2026)
- Lightspeed Venture Partners XV-B (Ignite), L.P.: 7.6% (Schedule 13G, filed May 18, 2026)
- Dimension Management, L.P.: 7.1% (Schedule 13D, filed May 15, 2026)